Why the study?
Does procainamide induce antinuclear antibodies and lupus syndrome in patients treated for cardiac arrhythmias?
Does procainamide induce antinuclear antibodies and lupus syndrome in patients treated for cardiac arrhythmias?
A high proportion of patients treated with procainamide develop antinuclear antibodies, suggesting the drug-induced lupus response is not limited to those with genetic predisposition.
Answers are grounded in this paper and cite their sources.
Procainamide use may warrant monitoring for lupus-like symptoms; extends evidence of drug-induced autoimmunity beyond genetic predisposition.
Sixteen patients were followed prospectively for the possible development of the lupus syndrome while being treated for cardiac arrhythmias with conventional doses of procainamide hydrochloride. In eight antinuclear antibody developed. Two of the eight had positive slide reactions with nucleoprotein-coated latex particles. In one of these two rheumatoid factor (anti-IgG) activity in low titer also developed. Another two of the eight showed symptoms consistent with the lupus syndrome. The high percentage of patients in this study in whom antinuclear antibody developed suggests that the lupus response appearing in patients treated with procainamide is not restricted to the small proportion of the population that may have a genetic predisposition to idiopathic lupus erythematosus.
No takes yet. Share an insight, caveat, or question.
Blomgren et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: